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Background
Selected patients with cardiac rhythm management
devices (CRMD) can safely undergo cardiovascular mag-
netic resonance (CMR). However, susceptibility artifacts
from CRMD generator and leads can affect image quality,
limiting the information provided by CMR. We sought to
evaluate whether CMR of CRMD patients can provide
clinically useful information that includes answering the
clinical question, providing new findings, new diagnoses,
or change in clinical management.
Methods
We studied 89 patients with CRMD who were evaluated
for CMR from November 2012 through June 2015.
Eighteen patients were excluded for various MRI contrain-
dications. The remaining 71 patients completed the scan
without complications. All CRMD were interrogated prior
to the scan. For pacemaker dependent patients, asynchro-
nous pacing was used during CMR. Device therapies were
turned off for implantable cardioverter defibrillator (ICD)
patients. CMR images were acquired on a 1.5 Tesla (Sie-
mens Aera) scanner using standard sequences including
single shot black blood imaging, cine with SSFP or
FLASH, first pass perfusion, and late gadolinium enhance-
ment (LGE). During the scan, patients were monitored
with continuous vitals, ECG, oximetry, and voice contact.
All CRMD were re-interrogated after the scan and original
settings were restored. Images were evaluated using
CMR42 (Circle Cardiovascular Imaging) software.
Results
Baseline characteristics are listed in Table 1. ICD was
present in 58 (81.7%) and pacemaker in 13 (18.3%)
patients. Common CMR indications included evaluation
for ventricular arrhythmia substrate (n = 61), hyper-
trophic cardiomyopathy (HCM) (n = 6), and cardiac sar-
coidosis (n = 4). Device artifact affected complete
evaluation of myocardial segments in 17 patients
(23.9%) on cine imaging and in 50 patients (70.4%) on
LGE. CMR findings are summarized in Table 2. The
most common findings were non-ischemic scar (n = 24),
ischemic scar (n = 17), and combined scar (n = 6), which
helped guide ventricular arrhythmia ablation. Addition-
ally, a new diagnosis or finding was made in 14 patients
(19.7%), which included cardiac sarcoidosis (n = 3) and
arrhythmogenic right ventricular cardiomyopathy (n = 2).
In 3 HCM patients, CMR findings guided the decision
for alcohol septal ablation vs. surgical resection. Overall,
the clinical question was answered in 66 patients (92.9%).
Conclusions
Our results show that in carefully screened CRMD
patients, CMR is safe, can answer the clinical question in
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Table 1 Baseline Clinical Characteristics
Age (years) 59.38 (± 12.95)
Male 59 (83.0%)
Body mass index (kg/m2) 29.54 (± 6.31)
Body surface area (m2) 2.09 (± 0.22)
Coronary artery disease 25 (35.7%)
Diabetes mellitus 9 (12.9%)
Hypertension 40 (57.0%)
Hyperlipidemia 37 (52.9%)
Ischemic cardiomyopathy 16 (22.9%)
Non-ischemic cardiomyopathy 24 (34.3%)
Mixed cardiomyopathy 6 (8.6%)
Previous ventricular arrhythmia ablation 24 (34.3%)
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vast majority of patients, and can provide new information
to guide clinical management.
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Table 2 CMR Findings
Non-ischemic scar 24 (33.8%)
Ischemic scar 17 (23.9%)
Combined ischemic and non-ischemic scar 6 (8.5%)
Hypertrophic cardiomyopathy 4 (5.6%)
Cardiac sarcoidosis 3 (4.2%)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) 3 (4.2%)
Left ventricular involvement of ARVC 2 (2.8%)
Rejected cardiac sarcoidosis 1 (1.4%)
Rejected ARVC 1 (1.4%)
Accessory pulmonary vein 1 (1.4%)
Apical thrombus 1 (1.4%)
Pericardial lipomatosis 1 (1.4%)
Right ventricular pseudoaneurysm 1 (1.4%)
Severe aortic stenosis 1 (1.4%)
Subaortic membrane 1 (1.4%)
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